Ads
related to: crispr therapeutics news
Search results
Is CRISPR Therapeutics a Buy in the New Bull Market?
Motley Fool via Yahoo Finance· 4 months agoCRISPR Therapeutics (NASDAQ: CRSP) soared 54% last year as growth stocks rallied and the company itself moved toward an important milestone: the approval...
Can CRISPR Therapeutics Stock Double in 5 Years? Here's What It Would Take.
Motley Fool· 7 months agoCRISPR Therapeutics (NASDAQ: CRSP) has reached a very exciting point in its story. The biotech...
If You Invested $5,000 in CRISPR Therapeutics in January, This Is How Much You Would Have Today
Motley Fool· 6 months agoCRISPR Therapeutics' (NASDAQ: CRSP) stock has soared this year -- and for good reason. The biotech...
Where Will CRISPR Therapeutics Be in 5 Years?
Motley Fool via Yahoo Finance· 6 months agoCRISPR Therapeutics (NASDAQ: CRSP) received great news last week. Its gene-editing therapy, which it has been developing with Vertex Pharmaceuticals,...
Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics
Motley Fool· 1 year agoCRISPR Therapeutics (NASDAQ: CRSP) is heading for an important moment: the potential approval of its...
Here's the 1 Key Reason You Might Want to Buy CRISPR Therapeutics Stock on the Dip
Motley Fool via Yahoo Finance· 6 months agoIt's now a new ballgame for CRISPR Therapeutics (NASDAQ: CRSP). The company, along with its big...
1 Setback and 1 Opportunity for CRISPR Therapeutics Stock
Motley Fool via Yahoo Finance· 4 months agoWith CRISPR Therapeutics (NASDAQ: CRSP) in the news thanks to its successful work in developing...
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
Motley Fool via Yahoo Finance· 6 months agoCRISPR Therapeutics (NASDAQ: CRSP) has climbed more than 60% this year -- and for good reason. The...
Crispr Therapeutics Stock Shows Rising Price Performance With Jump To 94 RS Rating
Investor's Business Daily· 2 years agoCrispr Therapeutics stock saw a positive improvement to its Relative Strength (RS) Rating on Friday,...
Is Now a Good Time to Buy CRISPR Therapeutics?
Motley Fool· 11 months agoCRISPR Therapeutics (NASDAQ: CRSP) may be a few months away from a transformation. CRISPR and big biotech partner Vertex Pharmaceuticals submitted...